ArticleThe Journal of biological chemistry2026
A monofunctional-like mutant of DNA glycosylase NTHL1 changes the dynamics of DNA repair during acute oxidative stress.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bifunctional DNA glycosylases, which initiate the base excision repair (BER) of oxidized bases, act by first excising the base and then incising the DNA backbone. In vitro, these enzymes are often rate-limited by their apurinic/apyrimidinic (AP)-lyase activity; however, the significance of this step in cells has remained unclear, because AP-endonuclease 1 (APE1) can efficiently bypass this step. To analyze the importance of the AP-lyase activity of NTHL1, we rationally designed and characterized a monofunctional-like NTHL1 mutant with glycosylase activity but profoundly impaired AP-lyase activity using complementary biochemical and microscopy-based assays. Mechanistically, we demonstrated that the monofunctional-like NTHL1 mutant generates abasic sites (AP sites) but, despite lacking effective AP-lyase activity, remains AP site bound. This creates competition with APE1 for engagement of AP sites. Moreover, cells expressing the monofunctional-like NTHL1 mutant accumulated more AP sites, retained higher levels of XRCC1 foci and displayed heightened sensitivity to acute oxidative stress. Live-cell assays further revealed increased NTHL1 accumulation at laser-induced DNA damage sites and increased chromatin bound immobility during oxidative stress, with mobility restored after a repair period. In contrast, a catalytically inactive NTHL1 mutant was recruited less strongly but remained chromatin-bound for a longer time. Thus, in contrast to the monofunctional-like NTHL1 mutant, the bifunctional NTHL1 limits BER intermediate retention and enables timely hand-off to downstream enzyme APE1. Ultimately, disrupting the AP-lyase ability of NTHL1 disrupts BER pathway flux and affects chromatin engagement during oxidative stress.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.